REVIEW ARTICLE
Perspectives of Immune Suppression in the Tumor Microenvironment Promoting Oral Malignancy
Nobuo Kondoh1, *, Masako Mizuno-Kamiya2, Eiji Takayama1, Harumi Kawati1, Naoki Umemura1, Yutaka Yamazaki3, Kenji Mitsudo4, Iwai Tohnai4
Article Information
Identifiers and Pagination:
Year: 2018Volume: 12
First Page: 455
Last Page: 465
Publisher ID: TODENTJ-12-455
DOI: 10.2174/1874210601812010455
Article History:
Received Date: 13/04/2018Revision Received Date: 15/05/2018
Acceptance Date: 29/05/2018
Electronic publication date: 20/6/2018
Collection year: 2018

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: (https://creativecommons.org/licenses/by/4.0/legalcode). This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Introduction:
In order to survive, cancers control immune systems and evade immune detection using mediators consisting of immune checkpoint molecules and cellular systems associated with immune suppression.
Methodology:
During the development of cancer and chronic infections, the immune checkpoints and cellular components including regulatory T cells, myeloid derived suppressor cells and cancer associated fibroblasts are often enhanced as a mechanism of immune subversion and have therefore become very important therapeutic targets.
Conclusion:
In this review, we will discuss the complexity of immune-suppressive mechanisms in the tumor milieu of cancers, including oral malignancy.